Philip Morris International (PMI) announced that the U.S. Food and Drug Administration (FDA) has authorized the commercialization of its ZYN smoke-free nicotine pouches as modified risk tobacco products (MRTPs). The… The post US Food and Drug Administration Authorizes Philip Morris International to Market ZYN as a Modified Risk Tobacco Product appeared first on Web-Release.